Gamma delta T cells in hepatocellular carcinoma: Sunrise of new therapy based on Vδ2 T cells?

Clin Transl Med. 2022 Apr;12(4):e834. doi: 10.1002/ctm2.834.

Author

Zuzana Macek Jilkova^{1

2

3}

Affiliations

¹ Université Grenoble Alpes, Grenoble, France.
² Institute for Advanced Biosciences, Research Center UGA/Inserm U 1209/CNRS 5309, La Tronche, France.
³ Service d'hépato-gastroentérologie, Pôle Digidune, CHU Grenoble Alpes, La Tronche, France.

No abstract available

Keywords: Hepatocellular carcinoma; tumour microenvironment; γδ T cells.

Publication types

Comment

MeSH terms

Carcinoma, Hepatocellular* / therapy
Humans
Intraepithelial Lymphocytes*
Liver Neoplasms* / therapy
Lymphocyte Count
Receptors, Antigen, T-Cell, gamma-delta

Substances

Receptors, Antigen, T-Cell, gamma-delta